Puma Biotechnology reported $9.1M in EBITDA for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Agios Pharmaceuticals AGIO:US $ -102.62M 13.68M
Cerulean Pharma CERU:US $ -9.54M 3.13M
Daiichi Sankyo 4568:JP Y 53257M 4M
Mirati Therapeutics MRTX:US $ -183.59M 12.92M
Novartis NOVN:VX SF 4214M 623M
Sangamo Biosciences SGMO:US $ -42.43M 5.29M
Tg Therapeutics TGTX:US $ -92.87M 7.82M